Stolle Milk Biologicals International

Stolle Milk Biologicals International (SMBI) is a biotechnology company that pioneered the development of hyperimmune milk, a functional food and therapeutic agent. Founded on the research of Ralph Stolle in 1958, the company uses a proprietary platform to immunize dairy cows against a wide range of human pathogens, resulting in milk that contains high levels of specific antibodies and anti-inflammatory factors. SMBI's products, including milk powders and protein concentrates, are clinically proven to support immune function, reduce cholesterol, and alleviate symptoms of inflammatory conditions like rheumatoid arthritis. The company holds an extensive global patent portfolio and operates primarily through licensing and distribution partnerships in the Asian and North American markets. Their technology represents a unique intersection of dairy science and immunology, providing natural, protein-based solutions for chronic health management.